This information has been developed to help you understand and make decisions about the use of trastuzumab (Herceptin®) for the treatment of early breast cancer.
This resource has been superseded in-full or in-part by Cancer Australia's trastuzumab information.
|File size:||111.04 KB|
|Cancer Type:||Breast cancer|
|Publication Audience:||Resources for health professionals|
This resource has been superseded in-full or in-part by an updated version. It is available to the public for research and reference purposes only. Cancer Australia assumes no legal liability or responsibility for errors or omissions contained within.